Search
Envista Holdings Corp
NVSTAdd to Watchlist
27.310USD
-0.460-1.66%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.45BMarket Cap
66.37P/E TTM
More Details of Envista Holdings Corp Company
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Envista Holdings Corp Info
Ticker SymbolNVST
Company nameEnvista Holdings Corp
IPO dateSep 18, 2019
CEOKeel (Paul A)
Number of employees12300
Security typeOrdinary Share
Fiscal year-endSep 18
Address200 S. Kraemer Blvd., Bldg. E
CityBREA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code92821
Phone17148175418
Websitehttps://envistaco.com/en
Ticker SymbolNVST
IPO dateSep 18, 2019
CEOKeel (Paul A)
Company Executives of Envista Holdings Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
42.49K
+21.96%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
FAQs
Who are the top five shareholders of Envista Holdings Corp?
The top five shareholders of Envista Holdings Corp are: Mr. Paul A. Keel
How many institutions hold shares of Envista Holdings Corp (NVST)?
As of 2026Q1, 711 institutions hold shares of Envista Holdings Corp, with a combined market value of approximately 203.45M, accounting for 125.03% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3285874.00.